Update in lipid alterations in subclinical hypothyroidism

Area of Science:

• Endocrinology
• Metabolic Disorders
• Lipid Metabolism

Background:

• Thyroid hormone critically regulates lipid metabolism, affecting synthesis, absorption, and breakdown.
• Overt hypothyroidism is linked to elevated total cholesterol, LDL-C, apolipoprotein B, and triglycerides, which normalize with levothyroxine.
• Subclinical hypothyroidism affects 1-11% of dyslipidemia patients, with unclear impacts on lipid profiles.

Purpose of the Study:

• To elucidate the effects of subclinical hypothyroidism on serum lipid values.
• To review the evidence regarding lipid alterations in subclinical hypothyroidism.
• To assess the impact of levothyroxine therapy on lipid profiles in subclinical hypothyroidism.

Main Methods:

• Review of existing studies on thyroid hormone and lipid metabolism.
• Analysis of lipid profiles (total cholesterol, LDL-C, triglycerides, apolipoprotein B, HDL-C, lipoprotein(a)) in overt and subclinical hypothyroidism.
• Evaluation of the effects of levothyroxine treatment on lipid parameters.

Main Results:

• Overt hypothyroidism consistently elevates LDL-C and other lipids, reversible with treatment.
• Subclinical hypothyroidism may increase apolipoprotein B; effects on total cholesterol and LDL-C are inconsistent across studies.
• Evidence suggests HDL-C and lipoprotein(a) are generally unaffected by subclinical hypothyroidism; triglyceride and LDL-C oxidizability data are inconsistent.
• Levothyroxine's benefit for lipids in subclinical hypothyroidism is not consistently demonstrated.

Conclusions:

• While overt hypothyroidism clearly impacts lipid profiles, the effects of subclinical hypothyroidism are less definitive and may vary.
• Factors like smoking and insulin resistance might influence lipid changes in subclinical hypothyroidism.
• Further research is needed to clarify the role of subclinical hypothyroidism in dyslipidemia and the efficacy of treatment.